Phase 1 TB Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
Low-Tech Treatments for Obstructive Sleep Apnea
Traumatic Brain Injury (TBI)Obstructive Sleep Apnea (OSA)
Uniformed Services University of the Health Sciences60 enrolled1 locationNCT07301710
Recruiting
Phase 1Phase 2
A Pilot, Multicentre, Controlled, Open-label Study Evaluating 24 Months of Lithium Carbonate Treatment in Patients With TBR1-related Neurocognitive Disorder
Proven Pathogenic or Probably Pathogenic TBR1 Variant
Centre Hospitalier Universitaire Dijon12 enrolled1 locationNCT06776848
Recruiting
Phase 1
Pharmacokinetic Study of Sudapyridine（WX-081）in Healthy Chinese Subjects
TB
Shanghai Jiatan Pharmatech Co., Ltd10 enrolled1 locationNCT06701110
Withdrawn
Phase 1
Repeatability and diurnal variation of eye responses measured with Neuro-Ophthalmic Device (NODe)
epilepsy or any type of seizureMild traumatic brain injury (mTBI) or concussionmedically diagnosed psychiatric disorder
Percy Lazon de la Jara20 enrolled1 locationACTRN12615000371594